Related Experiment Video
Updated: Sep 12, 2025
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
From Genes to Gut: Understanding Diagnosis and Treatment in Very Early Onset Inflammatory Bowel Disease
Casey Konys1, Yusuf Usman2, Joseph Runde3
1Children's Hospital of Chicago, Chicago, Illinois.
Insights
Very early onset inflammatory bowel disease (VEO-IBD) presents unique challenges. Early identification of monogenic forms and multidisciplinary care are crucial for improved outcomes in VEO-IBD.
Area of Science:
- Pediatric Gastroenterology
- Immunology
- Genetics
Background:
- Very early onset inflammatory bowel disease (VEO-IBD) is diagnosed before age 6.
- VEO-IBD has distinct clinical and therapeutic challenges compared to adult-onset IBD.
- Younger age of onset correlates with increased disease severity and poorer outcomes.
Purpose of the Study:
- To review clinical manifestations and management strategies for VEO-IBD.
- To differentiate between polygenic and monogenic forms of VEO-IBD.
- To highlight the importance of early diagnosis and targeted therapies.
Main Methods:
- Literature review of VEO-IBD.
- Analysis of clinical data differentiating polygenic and monogenic VEO-IBD.
- Synthesis of current management approaches and future research directions.
Main Results:
- VEO-IBD often presents with more extensive disease and worse prognosis.
- Monogenic VEO-IBD requires high suspicion for early identification.
- Multidisciplinary care is essential for managing VEO-IBD.
Conclusions:
- Early diagnosis of monogenic VEO-IBD enables targeted therapy and better prognosis.
- A comprehensive, multidisciplinary approach is vital for VEO-IBD patients.
- Future research in gene therapy and novel mechanisms promises precision medicine for VEO-IBD.
Abstract:
Very early onset inflammatory bowel disease (VEO-IBD), defined by a diagnosis of IBD before age 6 years, poses unique clinical and therapeutic challenges. This review examines differences in clinical manifestations and management for this population, noting important considerations between polygenic and monogenic forms of VEO-IBD. In general, a younger age of onset of IBD is associated with more extensive disease burden and more guarded outcomes compared with adults. For this reason, a comprehensive and multidisciplinary approach involving pediatricians, gastroenterologists, dietitians, and immunologists, among other subspecialties, is vital. Early identification of monogenic disease may allow for targeted therapy selection and improved prognosis, so a high index of suspicion from caretakers is needed. Moving forward, more real-world descriptions, prospective trials, and emerging studies on gene therapy and new mechanisms of action offer promise with a goal for a precision-based approach in this unique population.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: